Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

RM LAW Announces Investigation of Pardes Biosciences, Inc.

PRDS

BERWYN, Pa., Jan. 30, 2023 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Pardes Biosciences, Inc. ("Pardes" or the "Company") (NASDAQ: PRDS) investors concerning the Company's possible violations of the federal securities laws.

If you own shares of Pardes and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here. You may also email Mr. Maniskas at rm@maniskas.com.

RM Law is investigating potential violations of law in connection with the following special purpose acquisition company ("SPAC"): Pardes Biosciences, Inc. f/k/a FS Development Corp. II (NASDAQ: PRDS).

For more information regarding this, please contact RM LAW, P.C. (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at rm@maniskas.com or click here. For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here.

CONTACT: RM LAW, P.C.
Richard A. Maniskas, Esquire
1055 Westlakes Dr., Ste. 300
Berwyn, PA 19312
484-324-6800
844-291-9299
rm@maniskas.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rm-law-announces-investigation-of-pardes-biosciences-inc-301733776.html

SOURCE RM LAW, P.C.